Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001982476-23-000003
Filing Date
2023-09-08
Accepted
2023-09-08 10:22:39
Documents
1
Period of Report
2023-06-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 6358
  Complete submission text file 0001982476-23-000003.txt   7989
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Issuer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 650 GEORGIA ST #3200 VANCOUVER A1 V6B4P7
Business Address
Lichti Braeden (Reporting) CIK: 0001982476 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-53223 | Film No.: 231244058